John Overdeck’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-281,381
| Closed | -$49.8M | – | 3772 |
|
|
2020
Q1 | $49.8M | Sell |
281,381
-375,056
| -57% | -$70.6M | 0.41% | 36 |
|
|
2019
Q4 | $125M | Buy |
656,437
+515,127
| +365% | +$92.9M | 0.38% | 49 |
|
|
2019
Q3 | $23.8M | Buy |
+141,310
| New | +$23M | 0.08% | 307 |
|
|
2018
Q3 | – | Sell |
-2,102
| Closed | -$386K | – | 3787 |
|
|
2018
Q2 | $350K | Buy |
+2,102
| New | +$337K | ﹤0.01% | 2859 |
|
|
2018
Q1 | – | Sell |
-444,832
| Closed | -$74.6M | – | 3706 |
|
|
2017
Q4 | $72.8M | Buy |
+444,832
| New | +$79.8M | 0.24% | 108 |
|
|
2016
Q3 | – | Sell |
-65,302
| Closed | -$15.1M | – | 3486 |
|
|
2016
Q2 | $15.1M | Sell |
65,302
-536,603
| -89% | -$124M | 0.06% | 358 |
|
|
2016
Q1 | $161M | Buy |
601,905
+80,817
| +16% | +$23.1M | 0.77% | 9 |
|
|
2015
Q4 | $163M | Buy |
521,088
+514,188
| +7,452% | +$153M | 0.78% | 8 |
|
|
2015
Q3 | $1.88M | Buy |
6,900
+2,700
| +64% | +$829K | 0.01% | 876 |
|
|
2015
Q2 | $1.28M | Buy |
+4,200
| New | +$1.25M | 0.01% | 1494 |
|
|
2014
Q4 | – | Sell |
-373,189
| Closed | -$90M | – | 2457 |
|
|
2014
Q3 | $90M | Sell |
373,189
-362,609
| -49% | -$81.1M | 0.4% | 60 |
|
|
2014
Q2 | $164M | Buy |
735,798
+287,568
| +64% | +$59.5M | 0.74% | 3 |
|
|
2014
Q1 | $92.3M | Buy |
448,230
+428,700
| +2,195% | +$84.9M | 0.49% | 30 |
|
|
2013
Q4 | $3.28M | Sell |
19,530
-176,904
| -90% | -$27.7M | 0.02% | 781 |
|
|
2013
Q3 | $28.3M | Sell |
196,434
-336,327
| -63% | -$44.8M | 0.18% | 146 |
|
|
2013
Q2 | $67.2M | Buy |
+532,761
| New | +$60.3M | 0.47% | 37 |
|
Other funds holding AGN
JJ
John Overdeck's AGN Position: Q2 2020 in Review
John Overdeck sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 281,381 shares — an estimated $49.8M sold.
John Overdeck first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $164M in Q2 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- John Overdeck reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- John Overdeck sold 281,381 Allergan plc shares in Q2 2020, an estimated $49.8M.
- John Overdeck first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
- John Overdeck's Allergan plc position peaked at $164M in Q2 2014.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.